# Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD

> **NCT05650047** · — · UNKNOWN · sponsor: **Notal Vision Inc.** · enrollment: 15 (estimated)

## Conditions studied

- Retinal Neovascularization

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05650047
- **Lead sponsor:** Notal Vision Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-09-09
- **Primary completion:** 2023-07-26
- **Final completion:** 2023-09-09
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2023-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05650047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05650047, "Home OCT Guided Management Study of Subjects Diagnosed With Neovascular-AMD". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05650047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*